Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications

JL Bennett, O Stüve - Clinical neuropharmacology, 2009 - journals.lww.com
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system of uncertain etiology. There is consensus that a dysregulated …

Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications

JL Bennett, O Stüve - Clinical neuropharmacology, 2009 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system of uncertain etiology. There is consensus that a dysregulated …

Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications

JL Bennett, O Stüve - Clinical Neuropharmacology, 2009 - journals.lww.com
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system of uncertain etiology. There is consensus that a dysregulated …

Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: Therapeutic implications

JL Bennett, O Stüve - Clinical neuropharmacology, 2009 - utsouthwestern.elsevierpure.com
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system of uncertain etiology. There is consensus that a dysregulated …

Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications.

JL Bennett, O Stüve - Clinical Neuropharmacology, 2009 - europepmc.org
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease
of the central nervous system of uncertain etiology. There is consensus that a dysregulated …

[引用][C] Update on Inflammation, Neurodegeneration, and Immunoregulation in Multiple Sclerosis: Therapeutic Implications

JL BENNETT, O STÜVE - Clinical neuropharmacology, 2009 - Lippincott Williams & Wilkins